Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Nature Communications
|
September 4, 2015
Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures
Tommy Stödberg, Amy McTague, Arnaud J Ruiz, et al.
The Journal of Investigative Dermatology
|
December 25, 2022
PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma
Satyamaanasa Polubothu, Nicole Bender, Siobhan Muthiah, et al.
The Journal of Biological Chemistry
|
June 16, 2012
Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease
Eloisa Carta, Seo-Kyung Chung, Victoria M James, et al.
JCI Insight
|
February 23, 2026
Structural modeling and functional characterization of a novel gain-of-function TLR8 variant causing severe inflammatory syndrome
Nikolaos T Skenteris, Elisa Luttermann, Sanjana Nair, et al.
Proteins
|
October 9, 2025
Protein Target Highlights in CASP16: Insights From the Structure Providers
Leila T Alexander, Océane M Follonier, Andriy Kryshtafovych, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 25, 2022
MED27, SLC6A7, and MPPE1 Variants in a Complex Neurodevelopmental Disorder with Severe Dystonia
Kimberley M Reid, Robert Spaull, Smrithi Salian, et al.
Proteins
|
August 24, 2019
Target highlights in CASP13: Experimental target structures through the eyes of their authors
Rosalba Lepore, Andriy Kryshtafovych, Markus Alahuhta, et al.
Structure (London, England : 1993)
|
June 23, 2015
Outcome of the First wwPDB Hybrid/Integrative Methods Task Force Workshop
Andrej Sali, Helen M Berman, Torsten Schwede, et al.
Proteins
|
September 25, 2021
Target highlights in CASP14: Analysis of models by structure providers
Leila T Alexander, Rosalba Lepore, Andriy Kryshtafovych, et al.
The Journal of Clinical Investigation
|
November 2, 2018
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
Lara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Nature Communications
|
September 4, 2015
Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures
Tommy Stödberg, Amy McTague, Arnaud J Ruiz, et al.
The Journal of Investigative Dermatology
|
December 25, 2022
PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma
Satyamaanasa Polubothu, Nicole Bender, Siobhan Muthiah, et al.
The Journal of Biological Chemistry
|
June 16, 2012
Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease
Eloisa Carta, Seo-Kyung Chung, Victoria M James, et al.
JCI Insight
|
February 23, 2026
Structural modeling and functional characterization of a novel gain-of-function TLR8 variant causing severe inflammatory syndrome
Nikolaos T Skenteris, Elisa Luttermann, Sanjana Nair, et al.
Proteins
|
October 9, 2025
Protein Target Highlights in CASP16: Insights From the Structure Providers
Leila T Alexander, Océane M Follonier, Andriy Kryshtafovych, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 25, 2022
MED27, SLC6A7, and MPPE1 Variants in a Complex Neurodevelopmental Disorder with Severe Dystonia
Kimberley M Reid, Robert Spaull, Smrithi Salian, et al.
Proteins
|
August 24, 2019
Target highlights in CASP13: Experimental target structures through the eyes of their authors
Rosalba Lepore, Andriy Kryshtafovych, Markus Alahuhta, et al.
Structure (London, England : 1993)
|
June 23, 2015
Outcome of the First wwPDB Hybrid/Integrative Methods Task Force Workshop
Andrej Sali, Helen M Berman, Torsten Schwede, et al.
Proteins
|
September 25, 2021
Target highlights in CASP14: Analysis of models by structure providers
Leila T Alexander, Rosalba Lepore, Andriy Kryshtafovych, et al.
The Journal of Clinical Investigation
|
November 2, 2018
Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy
Lara Al-Olabi, Satyamaanasa Polubothu, Katherine Dowsett, et al.
Page
of 14